category,datetime,headline,id,image,related,source,summary,url
company,1768170600,Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion,138068851,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"CHICAGO, January 11, 2026--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a record Total Contract Value (TCV) of >$1.1 billion as of December 31, 2025. During 2025, Tempus signed data agreements with over 70 customers, spanning both large and mid-sized pharma, including AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, Pfizer, Novartis, Merck, Abbvie, Daiichi Sankyo, Eli Lilly, Boehringer Ingelheim, and biotechs inc",https://finnhub.io/api/news?id=75960b0138e2424bbca8b394a2f8ecb84d7afc9c5fc971f2a912f8ee845eacac
company,1768147380,This ETF Is Proof That the Healthcare Rebound Is Real,138075157,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"Track healthcare’s 2026 setup: GLP-1 drug adoption, a valuation gap vs. tech, and why VHT offers broad exposure with low fees and dividends.",https://finnhub.io/api/news?id=37f4d5b38f1ff502010ff587add70bfce19fea47b3f9d689eddcb7adcf089fbb
company,1768143300,This Healthcare Stock Could Be One of the Best Companies to Own in 2026,138068852,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,It has strong momentum thanks to its current portfolio and several catalysts on the horizon.,https://finnhub.io/api/news?id=d29d00cf70f5ffbe8eadbc2c80665b3306dc2912c19c33ec3f84d0f55ba37354
company,1768140025,Can Eli Lilly and Company's (NYSE:LLY) ROE Continue To Surpass The Industry Average?,138068853,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...",https://finnhub.io/api/news?id=38482ecd25cb447fcf33d55ff21c254c0ea2359734a6348ab741a29c9e634bc9
company,1768114660,"Novo Nordisk: Investor Confidence Up, But Caution Needed",138062829,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1219304819/image_1219304819.jpg?io=getty-c-w1536,LLY,SeekingAlpha,"Novo Nordisk faces slowing growth, competition, regulatory risks, and Wegovy pricing pressure, with DCF showing fair valuation. See why NVO stock is a hold.",https://finnhub.io/api/news?id=0d1620b04f650690355e85bf9e3c1b0e05b7a1cdf359071b344da6fd9e26b352
company,1768111219,ABIVAX Société Anonyme (ABVX) Rumored To Attract Interest From Eli Lilly,138068854,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"ABIVAX Société Anonyme (NASDAQ:ABVX) is among the 20 Best Performing Stocks in 2025. According to a story in the French-language newspaper La Tribune on December 24, 2025, there have been rumors that Eli Lilly has been drawing interest in the French biotechnology business ABIVAX Société Anonyme (NASDAQ:ABVX), TheFly reported. Its shares surged after the release, […]",https://finnhub.io/api/news?id=d3ac9cdeeb5b70dc1152e7afa5f3b0b424b96b8f1c2a8bece0428b04b2443278
